RT-30
|
Hypertrophic cardiomyopathy.
The implantable defibrillator
|
|
|
Martin Borggrefe, Michael Block,
Günter Breithardt.
Westfälische Wilhelms-University, Department of Cardiology and Angiology and
Institute for Research in Arteriosclerosis, Münster, Germany
|
|
References
|
1.
|
McKenna WJ:
Sudden death in hypertrophic cardiomyopathy: identification of the "high risk"
patient. In: Brugada P, Wellens HJJ (eds): Cardiac arrhythmias: where to go from here?
Mount Kisco, Futura Publishing, 1987; 353-365.
|
2.
|
McKenna WJ, England D, Dol YL, et al:
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
Br Heart J 1981; 46: 168-172.
|
3.
|
Cripps TR, Counihan PJ, Frenneaux MP, et al:
Signal-averaged electrocardiography in hypertrophic cardiomyopathy.
J Am Coll Cardiol 1990; 15: 956-961.
|
4.
|
Borggrefe M, Kuhn H, Königer HH, et al:
Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy.
Eur Heart J 1983; 4 (Suppl): 245-251.
|
5.
|
Borggrefe M, Martinez-Rubio A, Block M, et al:
Hypertrophic cardiomyopathy - Electrophysiologic findings and management of survivors of
cardiac arrest.
Eur Heart J 1989; 10 (Suppl): 316.
|
6.
|
McKenna WJ, Oakley CM, Krikler DM, et al:
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and
ventricular tachycardia.
Br Heart J 1985; 53: 412-416.
|
7.
|
Fananapazir L, Leon MB, Bonow RO, et al:
Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
Am J Cardiol 1991; 67: 169-174.
|
8.
|
Fananapazir L, Epstein SE:
Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with
amiodarone.
Am J Cardiol 1991; 67: 175-182.
|
